RSD1235-SR

· Advanz Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RSD1235-SR, covering 2008-12-18 to 2008-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter Recurrence [Phase 2]